Pharmamarketeer

Early clinical trial data in for whole virus COVID-19 vaccine candidate

COVID-19 vaccine

In a study uploaded to the preprint server medRxiv*, the efficacy of a whole virion Coronavirus vaccine was determined by giving the vaccine to healthy adult volunteers, which generated a robust immune response with evidence of T-cell activation.

Advertentie(s)